The retinoblastoma gene and its product are targeted by ICBP90: A key mechanism in the G1/S transition during the cell cycle

Oncogene

Volumn 24, Issue 49, 2005, Pages 7337-7345

  Jeanblanc, Michaël ^a,b   Mousli, Marc ^a   Hopfner, Raphaël ^a   Bathami, Kawtar ^a   Martinet, Nadine ^a   Abbady, Abdul Qader ^a   Siffert, Jean Claude ^c   Mathieu, Eric ^a   Muller, Christian D ^b   Bronner, Christian ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Centre Hospitalier de Belfort   (France)

Author keywords

Cell cycle; ICBP90; Methylated promoter; Retinoblastoma protein

Indexed keywords

CELL EXTRACT; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); GENE PRODUCT; INVERTED CCAAT BOX BINDING PROTEIN OF 90 KDA; MESSENGER RNA; PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL INTERACTION; CELL PROLIFERATION; CHROMATIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME SUBUNIT; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; LUNG FIBROBLAST; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; SERUM;

EID: 27744564626     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208878     Document Type: Article

References (51)

1. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR and Wahl GM. (1995). Proc. Natl. Acad. Sci. USA, 92, 5436-5440.
2. Angus SP, Fribourg AF, Markey MP, Williams SL, Horn HF, DeGregori J, Kowalik TF, Fukasawa K and Knudsen ES. (2002). Exp. Cell Res., 276, 201-213.
3. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H and Saya H. (2004). Genes Cells, 9, 131-142.
4. Bhattacharya S, Garriga J, Calbo J, Yong T, Haines DS and Grana X. (2003). Oncogene, 22, 2443-2451.
5. Betticher DC, White GR, Vonlanthen S, Liu X, Kappeler A, Altermatt HJ, Thatcher N and Heighway J. (1997). Int. J. Cancer, 74, 556-562.
6. Bonapace IM, Latella L, Papait R, Nicassio F, Sacco A, Muto M, Crescenzi M and Di Fiore PP. (2002). J. Cell Biol., 157, 909-914.
7. Bronner C, Hopfner R and Mousli M. (2002). Anticancer Res., 22, 605-612.
8. Chan HM, Smith L and La Thangue NB. (2001). Oncogene, 20, 6152-6163.
9. Chen PL, Riley DJ, Chen Y and Lee WH. (1996). Genes Dev., 10, 2794-2804.
10. Cheng CH and Kuchta RD. (1993). Biochemistry, 32, 8568-8574.
11. Christman JK. (2002). Oncogene, 21, 5483-5495.
12. Citterio E, Papait R, Nicassio F, Vecchi M, Gomiero P, Mantovani R, Di Fiore PP and Bonapace IM. (2004). Mol. Cell. Biol., 24, 2526-2535.
13. Coppola JA, Lewis BA and Cole MD. (1990). Oncogene, 5, 1731-1733.
14. Dyson N. (1998). Genes Dev., 12, 2245-2262.
15. Endo T and Goto S. (1992). J. Biochem. (Tokyo), 112, 427-430.
16. Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG and Rosen EM. (2001). Oncogene, 20, 4827-4841.
17. Fang X, Jin X, Xu HJ, Liu L, Peng HQ, Hogg D, Roth JA, Yu Y, Xu F, Bast Jr RC and Mills GB. (1998). Oncogene, 16, 1-8.
18. Gonzalez-Gomez P, Bello MJ, Alonso ME, Arjona D, Lomas J, de Campos JM, Isla A and Rey JA. (2003). Br. J. Cancer, 88, 109-114.
19. Grana X, Garriga J and Mayol X. (1998). Oncogene, 17, 3365-3383.
20. Hickman ES, Moroni MC and Helin K. (2002). Curr. Opin. Genet. Dev., 12, 60-66.
21. Hong FD, Huang HJ, To H, Young LJ, Oro A, Bookstein R, Lee EY and Lee WH. (1989). Proc. Natl. Acad. Sci. USA, 86, 5502-5506.
22. Hopfner R, Mousli M, Oudet P and Bronner C. (2002). Anticancer Res., 22, 3165-3170.
23. Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P and Bronner C. (2000). Cancer Res., 60, 121-128.
24. Kaelin WG. (1997). Cancer Invest., 15, 243-254.
25. Kaelin WG. (1999). Bioessays, 21, 950-958.
26. Macaluso M, Cinti C, Russo G, Russo A and Giordano A. (2003). Oncogene, 22, 3511-3517.
27. Meerson A, Milyavsky M and Rotter V. (2004). FEBS Lett., 559, 152-158.
28. Momparler RL. (2003). Oncogene, 22, 6479-6483.
29. Mousli M, Hopfner R, Abbady A, Monté D, Jeanblanc M, Oudet P, Louis B and Bronner C. (2003). Br. J. Cancer, 89, 120-127.
30. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A and Tatsumi K. (2002). J. Biol. Chem., 277, 34549-34555.
31. Nakamura M, Yonekawa Y, Kleihues P and Ohgaki H. (2001). Lab. Invest., 81, 77-82.
32. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE and Kouzarides T. (2001). Nature, 412, 561-565.
33. Pradhan S and Kim GD. (2002). EMBO J., 21, 779-788.
34. Richon VM, Rifkind RA and Marks PA. (1992). Cell Growth Differ., 3, 413-420.
35. Roncalli M, Bosari S, Marchetti A, Buttitta F, Bossi P, Graziani D, Peracchia A, Bonavina L, Viale G and Coggi G. (1998). Lab. Invest., 78, 1049-1057.
36. Simpson DJ, Frost SJ, Bicknell JE, Broome JC, McNicol AM, Clayton RN and Farrell WE. (2001). Carcinogenesis, 22, 1149-1154.
37. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN and Farrell WE. (2000). Cancer Res., 60, 1211-1216.
38. Slack RS, Hamel PA, Bladon TS, Gill RM and McBurney MW. (1993). Oncogens, 8, 1585-1591.
39. Strobeck MW, Fribourg AF, Puga A and Knudsen ES. (2000a). Oncogene, 19, 1857-1867.
40. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN and Knudsen ES. (2000b). Proc. Natl. Acad Sci. USA, 97, 7748-7753.
41. Trotzier MA, Bronner C, Bathami K, Mathieu E, Abbady AQ, Jeanblanc M, Muller CD, Rochette-Egly C and Mousli M. (2004). Biochem. Biophys. Res. Commun., 319, 590-595.
42. Unoki M, Nishidate T and Nakamura Y. (2004). Oncogene, 23, 7601-7610.
43. Vasquez RJ, Howell B, Yvon AM, Wadsworth P and Cassimeris L. (1997). Mol. Cell. Biol., 8, 973-985.
44. Wade PA. (2001). Hum. Mol. Genet., 10, 693-698.
45. Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID and Fountain JW. (1998). Genes Chromosomes Cancer, 22, 157-163.
46. Wang G, Miskimins R and Miskimins WK. (2000). Exp. Cell Res., 254, 64-71.
47. Wood A, Krogan NJ, Dover J, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, Zhang Y, Greenblatt JF, Johnston M and Shilatifard A. (2003). Mol. Cell, 11, 267-274.
48. Young AP and Longmore GD. (2004). Oncogene, 23, 2587-2599.
49. Zhang HS and Dean DC. (2001). Oncogene, 20, 3134-3138.
50. Zhang HS, Postigo AA and Dean DC. (1999). Cell, 97, 53-61.
51. Zhang Y. (2003). Genes Dev., 17, 2733-2740.